Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 7

ОБЗОР2025 · pp. 41–49

Blood exosomes of patients with malignant neoplasms of bones and articular cartilage: connection with tumor progression and practical value in clinical medicine

Relevance. Primary malignant neoplasms of bones and articular cartilage account for about 0.2% of all cancer cases and are characterized by an aggressive course, high tendency to metastasize, and resistance to therapy, which leads to unsatisfactory survival ra…

10.29296/24999490-2025-06-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 25–32

COMPARATIVE STUDY OF THE SOLUBLE FORMS OF IMMUNE CHECKPOINT PROTEINS VISTA, PD-1, PD-L1, AND BONE HOMEOSTASIS REGULATOR RANKL IN BONE TUMOR PATIENTS

Background. Low sensitivity of bone tumors to various schemes of standard chemotherapy stimulated the search of new targets for their medicamentous treatment. Among such targets are the so-called “immune checkpoints” promoting the escape of the tumor from the …

10.29296/24999490-2022-06-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

MATRIX METALLOPROTEINESES AND THEIR TISSUE INHIBITORS IN PRIMARY BONE TUMOR PATIENTS: CLINICAL AND PATHOLOGIC CORRELATIONS

Introduction. The search of molecular markers for early diagnostics, prognosis, and identification of new objects for molecular-targeted therapy of primary bone tumors remains one of the most important tasks despite the significant achievements in the treatmen…

10.29296/24999490-2018-05-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

RANK/RANKL/OPG SYSTEM COMPONENTS AND INTERLEUKINS 6, 8 16 IN BLOOD SERUM OF PATIENTS WITH PRIMARY BONE NEOPLASMS

Introduction. RANK/RANKL/OPG ligand-receptor system is a key player in bone tissue homeostasis directly regulating osteoclast differentiation and osteolysis. Many pathologic processes imposed by impairments in bone remodeling including tumor growth and metasta…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

PROGNOSTIC SIGNIFICANCE OF SERUM INSULIN-LIKE GROWTH FACTORS (IGF) AND IGF-BINDING PROTEINS LEVELS IN BONE SARCOMA PATIENTS

Introduction. Insulin-like growth factors (IGF) signaling system plays a major role in the development and progression of various sarcomas and other solid tumors, and therefore its components are regarded as promising diagnostic and prognostic tumor markers an…

Details ↗
Research article2014

INTERLEUKIN 16 IN THE SERUM BONE

Introduction. Progress in the treatment of cancer and bone tumors including, is associated with a significant breakthrough in molecular biology, immunology, understanding the causes of the emergence of the tumor cell, patterns of the development and course of …

Details ↗
Research article2014

TUMOR-ASSOCIATED METALLOPROTEINASES IN SERUM OF PRIMARY BONE SARCOMA PATIENTS

Introduction. Matrix metalloproteinase (MMP) – a family of extracellular zinc-containing proteases. There are currently 25 known MMP. Increased activity of MMP observed in some physiological processes – during the follicular phase of the menstrual cycle and du…

Details ↗

Article search and quick navigation

Navigation